Moors & Cabot, Inc. - REXAHN PHARMACEUTICALS INC ownership

REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 38 filers reported holding REXAHN PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Moors & Cabot, Inc. ownership history of REXAHN PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2015$7,000
-41.7%
11,000
-38.9%
0.00%
-50.0%
Q4 2014$12,000
-36.8%
18,000
-28.0%
0.00%
-33.3%
Q3 2014$19,000
-13.6%
25,0000.0%0.00%
-25.0%
Q2 2014$22,000
+83.3%
25,000
+127.3%
0.00%
+33.3%
Q1 2014$12,00011,0000.00%
Other shareholders
REXAHN PHARMACEUTICALS INC shareholders Q4 2014
NameSharesValueWeighting ↓
Northeast Financial Consultants Inc 150,000$105,0000.06%
Benin Management CORP 83,000$58,0000.03%
CONDOR CAPITAL MANAGEMENT 121,324$85,0000.02%
First Heartland Consultants, Inc. 30,000$21,0000.01%
FCG ADVISORS, LLC 15,000$11,0000.01%
Advisory Services Network, LLC 22,000$16,0000.01%
Virtu KCG Holdings LLC 346,822$243,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 180,000$126,0000.00%
Moors & Cabot, Inc. 18,000$12,0000.00%
Corbenic Partners LLC 1,600$1,0000.00%
View complete list of REXAHN PHARMACEUTICALS INC shareholders